一株鸭源传染性支气管炎病毒的分离鉴定及结构蛋白基因和血清型分析

【目的】对从广西某鸭场发生呼吸道感染的11天龄樱桃谷肉鸭分离到的病毒株进行鉴定,并探索此鸭源病毒分离株的遗传变异情况。【方法】通过血凝试验、鸡胚接种实验、3?端非编码区(3'UTR)基因扩增与序列测定对分离株进行鉴定,并对该分离株的结构基因S1、E、M和N分别进行序列测定以及相似性、系统进化树分析和血清型鉴定。【结果】血凝试验为阴性,接种鸡胚盲传5代后出现侏儒胚,3?UTR基因测序结果表明为传染性支气管炎病毒(IBV)序列。该分离株S蛋白的裂解位点为RRSRR,S1、E、M和N基因与IBV毒株H120、4/91、LTD3核苷酸相似性分别为:78.6%–99.7%、85.4%–100.0%、91.6%–93.2%、86.7%–91.7%。除N基因存在点突变外,S1、E和M基因均存在氨基酸的突变、插入和(或)缺失。系统进化树分析显示,其S1基因属于4/91型,E、M和N基因均为LDT3型。血清型分析表明,该分离株的血清型不同于疫苗株H120和4/91。【结论】此鸭源病毒分离株为IBV,且该分离株的基因型与血清型均发生了变异。本研究结果暗示禽类传染性支气管炎的防控面临着更严峻的挑战。     

Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits

1. Download high-res image (264KB)
2. Download full-size image

     

产L-乳酸凝结芽孢杆菌发酵条件的初步研究

对经N+离子注入筛选到的L-乳酸高产菌株BacilluscoagulansRS12-6的发酵条件进行了初步研究。主要研究了 通气量、温度及pH值等培养条件对菌体生长及产酸的影响。确定最佳培养条件及最佳碳源、氮源配比。     

乳糖对产木聚糖酶基因工程菌1020的诱导作用及碳氮源优化

研究了国产及进口LB培养基对产嗜热性木聚糖酶基因工程菌1020生长及产酶的影响,并以国产原料为基准,优化了培养基。结果表明,国产的酵母膏及蛋白胨和进口原料相比,缺少某些成分,单纯增加用量不能弥补这种差别;乳糖可以代替昂贵的IPTG起到有效的诱导作用;10g·L-1的乳糖可兼起能源及诱导剂的双重效果,菌的生物量和产酶量达到最佳;发酵8h后补加5g·L-1乳糖,生物量及酶活皆有提高。复合氮源优于单一的无机或有机氮源。优化后的酶活从进口LB培养基的270U～290U提高到1700U～1800U。     

细胞周期调控的研究进展

细胞周期是一种非常复杂和精细的调节过程,有大量调节蛋白参与其中。此过程的核心是细胞周期依赖性蛋白激酶（CDKs）。CDKs的激活又依赖于另一类呈细胞周期特异性或时相性表达的细胞周期蛋白（cyclins）,而CDKs调节的关键步骤是细胞周期检查点。PLKs是多种细胞周期检查点的主要调节因子,Aurora蛋白激酶主要在细胞有丝分裂期起作用。本文就上述因素在细胞周期进程中的作用作一综述。     

口腔鳞状细胞癌中VEGF、Bcl-2的表达及意义

目的研究血管内皮细胞生长因子VEGF、Bcl-2在口腔鳞状细胞癌(OSCC)中的表达及意义。方法应用免疫组化SP法检测。结果在OSCC不同分化及TNM分期病例中VEGF阳性表达率无显著差异,但Ⅳ期VEGF阳性表达级别比Ⅰ期病例有显著增高。颈淋巴结转移组的VEGF比无颈淋巴结转移组阳性率高(P<0.05)。OSCC高分化组中Bcl-2的表达率比中低分化组明显低(P<0.05)。VEGF阳性级别越高的病例组,Bc-l2的表达率越高。结论在口腔鳞癌中VEGF、Bcl-2的表达有显著的正相关关系。     

不同干预时间正弦电磁场对大鼠骨髓基质干细胞成骨性分化的影响

目的:研究不同治疗时间正弦电磁场(50 Hz,1.8mT)对体外培养大鼠骨髓间充质干细胞成骨性分化的影响,筛选出最佳临床治疗时间.方法:采用贴壁筛选法培养原代大鼠骨髓间充质干细胞,每天在频率为50 Hz,强度为1.8 mT的磁场环境中处理0.5 h、1.0h、1.5 h、2.0h和2.5h;同时设立未经电磁场处理的细胞作为对照组.于处理后的第3 d、6d、9d和12 d分别测定细胞碱性磷酸酶活性、骨钙素分泌量、钙化结节数以及Ⅰ型胶原表达量,并比较各组间差异;于处理后12 h提取细胞总RNA,用RT Real-Time PCR法检测成骨性分化基因Osterix表达情况.结果:正弦电磁场干预1.0h能明显促进骨髓间充质干细胞的成骨性分化,表现在该组的碱性磷酸酶活性、骨钙素分泌量、钙化结节数、Ⅰ型胶原表达量以及成骨性分化基因的表达量最高,亦显著高于对照组(P＜0.05).结论:50Hz、1.8mT强度的正弦电磁场能促进骨髓间充质干细胞的成骨性分化,以作用1.0h成骨效果最为明显.     

Activation of gibberellin 2-oxidase 6 decreases active gibberellin levels and creates a dominant semi-dwarf phenotype in rice （Oryza sativa L.）

Gibberellin (GA) 2-oxidase plays a key role in the GA catabolic pathway through 2β-hydroxylation.In the present study,we isolated a CaMV 35S-enhancer activation tagged mutant,H032.This mutant exhibited a dominant dwarf and GA-deficient phenotype,with a final stature that was less than half of its wild-type counterpart.The endogenous bioactive GAs are markedly decreased in the H032 mutant,and application of bioactive GAs (GA3 or GA4) can reverse the dwarf phenotype.The integrated T-DNA was detected 12.8 kb upstream of the OsGA2ox6 in the H032 genome by TAIL-PCR.An increased level of OsGA2ox6 mRNA was detected at a high level in the H032 mutant,which might be due to the enhancer role of the CaMV 35S promoter.RNAi and ectopic expression analysis of OsGA2ox6 indicated that the dwarf trait and the decreased levels of bioactive GAs in the H032 mutant were a result of the up-regulation of the OsGA2ox6 gene.BLASTP analysis revealed that OsGA2ox6 belongs to the class III of GA 2-oxidases,which is a novel type of GA2ox that uses C20-GAs (GA12 and/or GA53) as the substrates.Interestingly,we found that a GA biosynthesis inhibitor,paclobutrazol,positively regulated the OsGA2ox6 gene.Unlike the over-expression of OsGA2ox1,which led to a high rate of seed abortion,the H032 mutant retained normal flowering and seed production.These results indicate that OsGA2ox6 mainly affects plant stature,and the dominant dwarf trait of the H032 mutant can be used as an efficient dwarf resource in rice breeding.     

长白山阔叶红松林灌木物种组成、结构和空间分布

以长白山阔叶红松林25 hm2动态监测样地为平台,基于样地内600个5 m×5 m样方的调查数据,对灌木的物种组成、基本特征、结构和空间分布等进行了初步研究.结果表明:共调查到18种灌木,以东北山梅花、毛榛和簇毛槭为主要优势种;调查样方共记录灌木个体6435个和灌木枝干11369个,其中东北山梅花的个体数和枝干数最多,分别占总数的40.6%和33.4%;不同灌木的成丛率、每丛枝干的数量、冠幅和基径均存在明显的差异;不同灌木在高度上有较为明显的分化,灌木群落成层现象明显;优势种东北山梅花分布广泛,而珍珠梅、石蚕叶绣线菊、柳叶绣线菊和瘤枝卫矛的空间分布则呈现出较明显的异质性.     

Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis

Arterial ischemia and hemorrhage are associated with bevacizumab, an inhibitor of vascular endothelial growth factor that is widely used to treat many types of cancers. As specific types of arterial ischemia and hemorrhage, cerebrovascular events such as central nervous system (CNS) ischemic events and CNS hemorrhage are serious adverse events. However, increased cerebrovascular events have not been uniformly reported by previous studies. New randomized controlled trials (RCTs) have been reported in recent years and we therefore conducted an up-to-date meta-analysis of RCTs to fully characterize the risk of cerebrovascular events with bevacizumab. We searched the databases of PubMed, Web of Science, and the American Society of Clinical Oncology conferences to identify relevant clinical trials up to February 2014. Eligible studies included prospective RCTs that directly compared patients with cancer treated with and without bevacizumab. A total of 12,917 patients from 17 RCTs were included in our analysis. Patients treated with bevacizumab had a significantly increased risk of cerebrovascular events compared with patients treated with control medication, with a relative risk of 3.28 (95% CI, 1.97–5.48). The risks of CNS ischemic events and CNS hemorrhage were increased compared with control, with RRs of 3.22 (95% CI, 1.71–6.07) and 3.09 (95% CI, 1.36–6.99), respectively. Risk varied with the bevacizumab dose, with RRs of 3.97 (95% CI, 2.15–7.36) and 1.96 (95% CI, 0.76–5.06) at 5 and 2.5 mg/kg/week, respectively. Higher risks were observed in patients with metastatic colorectal cancer (RR, 6.42; 95% CI, 1.76–35.57), and no significant risk was observed in other types of tumors. In conclusion, the addition of bevacizumab significantly increased the risk of cerebrovascular events compared with controls, including CNS ischemic events and CNS hemorrhage. The risk may vary with bevacizumab dose and tumor type.